Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Pancreatic Neoplasms

methylprednisolone hemisuccinate has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, S; Hirota, M; Inoue, Y; Nomura, M; Sakao, J; Souda, S1

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Pancreatic Neoplasms

ArticleYear
[A case of drug-induced interstitial pneumonitis after gemcitabine treatment for advanced pancreatic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Diseases, Interstitial; Methylprednisolone Hemisuccinate; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Prednisolone; Pulse Therapy, Drug; Tomography, X-Ray Computed

2006